Ann Intern Med
- HUITS R, Grubaugh ND, Libman M, Hamer DH, et al
Resurgence of Dengue in the Era of Genomic Surveillance and Vaccines.
Ann Intern Med. 2024 Mar 19. doi: 10.7326/M24-0496.
- JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A
Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized
Implementation Trial.
Ann Intern Med. 2024 Mar 19. doi: 10.7326/M23-2638.
BMJ
- WISE J
RSV: Paediatricians call on government to expedite infant vaccination programme.
BMJ. 2024;384:q706.
- LEEDOM M
How climate change is changing vaccination planning.
BMJ. 2024;384:q360.
J Infect
- SALMAN M, Rana MS, Usman M, Tahir M, et al
Re-emergence of Diphtheria after COVID-19 Pandemic in Pakistan: time to consider
booster vaccination strategies.
J Infect. 2024 Mar 19:106141. doi: 10.1016/j.jinf.2024.106141.
- SUN L, Man Q, Zhang H, Xia S, et al
Strong cross immune responses against sarbecoviruses but not merbecoviruses in
SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19
vaccination.
J Infect. 2024;88:106138.
J Infect Dis
- FIGUEROA AL, Azzi JR, Eghtesad B, Priddy F, et al
Safety and Immunogenicity of the mRNA-1273 COVID-19 Vaccine in Solid Organ
Transplant Recipients.
J Infect Dis. 2024 Mar 21:jiae140. doi: 10.1093.
- PRUNAS O, Shioda K, Toscano CM, Bastias M, et al
Estimated population-level impact of pneumococcal conjugate vaccines against
all-cause pneumonia mortality among unvaccinated age groups in five Latin
American countries.
J Infect Dis. 2024 Mar 19:jiae144. doi: 10.1093.
- KING LM, Andrejko KL, Kabbani S, Tartof SY, et al
Outpatient visits and antibiotic use due to higher valency pneumococcal vaccine
serotypes.
J Infect Dis. 2024 Mar 18:jiae142. doi: 10.1093.
J Virol
- NUNBERG JH, Westover JB, York J, Jung KH, et al
Restoration of virulence in the attenuated Candid#1 vaccine virus requires
reversion at both positions 168 and 427 in the envelope glycoprotein GPC.
J Virol. 2024 Mar 20:e0011224. doi: 10.1128/jvi.00112.
- MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
The varying extent of humoral and cellular immune responses to either vector- or
RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent
of infection.
J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
- KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein
among influenza D virus lineages revealed using epitope mapping.
J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
- LI H, Sun H, Tao M, Han Q, et al
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin
protein confers broad protection against H5Ny influenza viruses.
J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
JAMA
- EDWARDS KM, Griffin MR
Postmarketing Vaccine Safety Assessments: Important Work in Progress.
JAMA. 2024;331:915-917.
- LU Y, Matuska K, Nadimpalli G, Ma Y, et al
Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
JAMA. 2024;331:938-950.
N Engl J Med
- HAVIARI S, Massonnaud CR, Dupont A
Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155.
- WOO EJ, Hulse AN
Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155-1156.
- HSIAO A, Fireman B, Klein NP
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
N Engl J Med. 2024;390:1156.
Pediatr Infect Dis J
- PLOTKIN SA, Offit P
Efficacy of Rotavirus Vaccines.
Pediatr Infect Dis J. 2024 Mar 20. doi: 10.1097/INF.0000000000004319.
- MEYER J, Silas P, Ouedraogo GL, McElwee K, et al
A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a
20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through
<18 Years of Age.
Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004318.
- MAROM T, Ovnat Tamir S
Pediatric Otitis Media in the New Pneumococcal Conjugate Vaccines Era: What's
Next?
Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004323.
PLoS Med
- MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus
bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy
adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med. 2024;21:e1004360.
PLoS One
- WALSH-BUHI ML, Houghton RF, Valdez D, Walsh-Buhi ER, et al
A theory-based assessment of mpox: Findings from a nationally representative
survey of U.S. adults.
PLoS One. 2024;19:e0299599.
- STOSIC M, Plavsa D, Jovanovic V, Veljkovic M, et al
Factors associated with COVID-19 among hospitalized patients with severe acute
respiratory infections in Serbia, 2022-2023: A test negative case-control study.
PLoS One. 2024;19:e0299210.
- UMER BA, Noyce RS, Kieser Q, Favis NA, et al
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in
mouse mammary tumor models.
PLoS One. 2024;19:e0298437.
- TRZEBINSKI W, Trzebinski J
How does collectivism help deal with perceived vaccine artificiality? The case of
COVID-19 vaccination intent in European young adults.
PLoS One. 2024;19:e0300814.
- KOSKAN A, Larkey L, Todd M, Kim SW, et al
Protocol for a community-based digital storytelling pilot intervention to reduce
Hispanic parents' vaccine hesitancy to immunize their children against COVID-19.
PLoS One. 2024;19:e0299787.
- ZHENG D, Sun Q, Su Z, Kong F, et al
Correction: Enhancing Specific-Antibody Production to the ragB Vaccine with GITRL
That Expand Tfh, IFN-gamma+ T Cells and Attenuates Porphyromonas gingivalis Infection
in Mice.
PLoS One. 2024;19:e0301151.
- GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
Web-based survey investigating cardiovascular complications in hypermobile
Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
PLoS One. 2024;19:e0298272.
- LANZA-LEON P, Cantarero-Prieto D, Pascual-Saez M
Exploring trends and determinants of basic childhood vaccination coverage:
Empirical evidence over 41 years.
PLoS One. 2024;19:e0300404.
- LI Y, Li J, He J, Tao C, et al
AE-GPT: Using Large Language Models to extract adverse events from surveillance
reports-A use case with influenza vaccine adverse events.
PLoS One. 2024;19:e0300919.
- LEE DH, Lee SH, Kim AR, Quan FS, et al
Correction: Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma
gondii.
PLoS One. 2024;19:e0301214.
- TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants
Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration,
symptom severity and viral kinetics, irrespective of vaccination history.
PLoS One. 2024;19:e0294897.
- LEE KS, Go MJ, Choi YY, Kim MK, et al
Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant
period in Korea; using K-COV-N cohort in the National health insurance service.
PLoS One. 2024;19:e0300306.
Vaccine
- MOFFETT KW, Seserman K, Margolis KA, Kranzler EC, et al
Differences in social media use by COVID-19 vaccination status.
Vaccine. 2024 Mar 20:S0264-410X(24)00318-9. doi: 10.1016/j.vaccine.2024.
- SASI A, Dandotiya J, Kaushal J, Ganguly S, et al
Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA
vaccines in adolescent/young adults with cancer: A prospective cohort study.
Vaccine. 2024 Mar 20:S0264-410X(24)00329-3. doi: 10.1016/j.vaccine.2024.
- BROOKS SP, Sidhu K, Cooper E, Michelle Driedger S, et al
The influence of health service interactions and local policies on vaccination
decision-making in immigrant women: A multi-site Canadian qualitative study.
Vaccine. 2024 Mar 20:S0264-410X(24)00299-8. doi: 10.1016/j.vaccine.2024.
- CRISTINA MARTINI RODRIGUES C, Caroline Ribeiro Sales A, Marli Christovam Sartori A, de Souza Azevedo A, et al
Yellow fever neutralizing antibody seroprevalence proportion and titers in
previously vaccinated adults with chronic kidney disease.
Vaccine. 2024 Mar 20:S0264-410X(24)00316-5. doi: 10.1016/j.vaccine.2024.
- ARTIGAS-JERONIMO S, Villar M, Estrada-Pena A, Alberdi P, et al
Subolesin knockdown in tick cells provides insights into vaccine protective
mechanisms.
Vaccine. 2024 Mar 19:S0264-410X(24)00278-0. doi: 10.1016/j.vaccine.2024.
- CHENG Y, Shen R, Liu F, Li Y, et al
Humoral and cellular immune responses induced by serogroup W135 meningococcal
conjugate and polysaccharide vaccines.
Vaccine. 2024 Mar 19:S0264-410X(24)00326-8. doi: 10.1016/j.vaccine.2024.
- KRASILNIKOV I, Isaev A, Djonovic M, Ivanov A, et al
Transformative vaccination: A pentavalent shield against COVID-19 and influenza
with betulin-based adjuvant for enhanced immunity.
Vaccine. 2024 Mar 19:S0264-410X(23)01421-4. doi: 10.1016/j.vaccine.2023.
- GEHRT L, Englund H, Laake I, Nieminen H, et al
Is vaccination against measles, mumps, and rubella associated with reduced rates
of antibiotic treatments among children below the age of 2 years? Nationwide
register-based study from Denmark, Finland, Norway, and Sweden.
Vaccine. 2024 Mar 19:S0264-410X(24)00313-X. doi: 10.1016/j.vaccine.2024.
- SANCHEZ-MARTINEZ ZV, Alpuche-Lazcano SP, Stuible M, Durocher Y, et al
CHO cells for virus-like particle and subunit vaccine manufacturing.
Vaccine. 2024 Mar 18:S0264-410X(24)00321-9. doi: 10.1016/j.vaccine.2024.
- WU J, Jiang L, Shao Q, Liu J, et al
Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant
inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78
challenge.
Vaccine. 2024 Mar 18:S0264-410X(24)00325-6. doi: 10.1016/j.vaccine.2024.
- MEDENI V, Altiner OT, Medeni I
Measles vaccination coverage and immunization status of nurses: An interventional
study in Turkiye.
Vaccine. 2024 Mar 18:S0264-410X(24)00324-4. doi: 10.1016/j.vaccine.2024.
- DANGOR Z, Benson N, Berkley JA, Bielicki J, et al
Vaccine value profile for Klebsiella pneumoniae.
Vaccine. 2024 Mar 18:S0264-410X(24)00248-2. doi: 10.1016/j.vaccine.2024.
- OPMEER L, Gazzoli I, Ballmann M, Willemsen M, et al
High throughput AS LNA qPCR method for the detection of a specific mutation in
poliovirus vaccine strains.
Vaccine. 2024 Mar 18:S0264-410X(24)00130-0. doi: 10.1016/j.vaccine.2024.
- MULLER T, Wallace RM, Freuling CM
Rabies importation in dogs and reduction of waiting period - The fear for
scientifically justified changes.
Vaccine. 2023 Oct 20:S0264-410X(23)01043-5. doi: 10.1016/j.vaccine.2023.
- HYAMS C, Lahuerta M, Theilacker C, King J, et al
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower
respiratory tract infection in Bristol, UK.
Vaccine. 2024;42:1599-1607.
- ZIBOLENOVA J, Malobicka E, Ulbrichtova R, Novak M, et al
Probability of exposure to the wild measles virus in adult population -
Estimation from seroepidemiology and historical data.
Vaccine. 2024;42:1648-1655.
- KWON KW, Choi HG, Choi HH, Choi E, et al
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase,
against Mycobacterium tuberculosis Beijing outbreak strains.
Vaccine. 2024;42:1941-1952.
- KOCHHAR S, Assis DN, Mack C, Izurieta HS, et al
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for
data collection, analysis, and presentation of immunisation safety data.
Vaccine. 2024 Feb 16:S0264-410X(24)00021-5. doi: 10.1016/j.vaccine.2024.
- SOVIK WLM, Madsen AMR, Aaby P, Nielsen S, et al
The association between BCG scars and self-reported chronic diseases: A
cross-sectional observational study within an RCT of Danish health care workers.
Vaccine. 2024;42:1966-1972.
- LLOYD PC, Lufkin B, Moll K, Ogilvie RP, et al
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults
in United States commercial and Medicare claims databases, 2017-2020.
Vaccine. 2024;42:2004-2010.
- ANWARI P, Burnett E, Chavers TP, Samsor A, et al
Post-marketing surveillance of intussusception after Rotarix administration in
Afghanistan, 2018-2022.
Vaccine. 2024;42:2059-2064.
- MACKENZIE GA, Hossain I, Salaudeen R, Badji H, et al
Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal
carriage in the Gambia: Population-based cross-sectional surveys.
Vaccine. 2024 Mar 14:S0264-410X(24)00225-1. doi: 10.1016/j.vaccine.2024.
- CAMERON DB, Grage L, Van Wyck R, Edwards A, et al
Identifying trusted local sources and predicting behavior change pathways
according to COVID-19 vaccination status: Results of a 2022 statewide survey of
Alaskan adults.
Vaccine. 2024 Mar 14:S0264-410X(24)00314-1. doi: 10.1016/j.vaccine.2024.
- JUNEAU C, Fall E, Bros J, Le Duc-Banaszuk AS, et al
Do boys have the same intentions to get the HPV vaccine as girls? Knowledge,
attitudes, and intentions in France.
Vaccine. 2024 Mar 14:S0264-410X(24)00256-1. doi: 10.1016/j.vaccine.2024.
- COTTON SA, Subramanian A, Hughes TD, Huang Y, et al
The effect of SARS-COV-2 variant on non-respiratory features and mortality among
vaccinated and non-fully vaccinated patients.
Vaccine. 2024 Mar 14:S0264-410X(24)00195-6. doi: 10.1016/j.vaccine.2024.
- FIX J, Christopher Mast T, Smith K, Baker N, et al
Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
Vaccine. 2024 Mar 16:S0264-410X(24)00323-2. doi: 10.1016/j.vaccine.2024.
- HARTMEIER PR, Ostrowski SM, Busch EE, Empey KM, et al
Lymphatic distribution considerations for subunit vaccine design and development.
Vaccine. 2024 Mar 16:S0264-410X(24)00320-7. doi: 10.1016/j.vaccine.2024.
- FIERRO C, Weidenthaler H, Vidojkovic S, Schmidt D, et al
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine
encephalitis virus vaccine: A Phase 1 clinical trial.
Vaccine. 2024 Mar 16:S0264-410X(24)00296-2. doi: 10.1016/j.vaccine.2024.
- CAMPAGNA R, Dominelli F, Zingaropoli MA, Ciurluini F, et al
COVID-19 vaccination in cancer patients: Immune responses one year after the
third dose.
Vaccine. 2024 Mar 17:S0264-410X(24)00304-9. doi: 10.1016/j.vaccine.2024.
Virology
- AMOSOVA IV, Timoshicheva TA, Kadyrova RA, Zabrodskaya YA, et al
The investigation of the dynamics of changes in neutralizing antibody titers
against type 5 adenovirus in the context of vaccination against a new coronavirus
infection.
Virology. 2024;594:110051.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016